For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Melnick Lab

Publications

2018

Untangling the Role of Polycomb Complexes in Chemotherapy Resistance., C. Duy; A. Melnick, Cancer Discov, 2018 11, 8, 11, p.1348-1351, (2018) PubMed

2017

The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target., M.G. Cardenas; E. Oswald; W. Yu; F. Xue; A.D. MacKerell; A.M. Melnick, Clin Cancer Res, 2017 Feb 15, 23, 4, p.885-893, (2017) PubMed
Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015., R.D. Gascoyne; B. Nadel; L. Pasqualucci; J. Fitzgibbon; J.E. Payton; A. Melnick; O. Weigert; K. Tarte; J.G. Gribben; J.W. Friedberg; J.F. Seymour; F. Cavalli; E. Zucca, Hematol Oncol, 2017 Dec, 35, 4, p.397-407, (2017) PubMed
The N-methyladenosine (mA)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells., L.P. Vu; B.F. Pickering; Y. Cheng; S. Zaccara; D. Nguyen; G. Minuesa; T. Chou; A. Chow; Y. Saletore; M. MacKay; J. Schulman; C. Famulare; M. Patel; V.M. Klimek; F.E. Garrett-Bakelman; A. Melnick; M. Carroll; C.E. Mason; S.R. Jaffrey; M.G. Kharas, Nat Med, 2017 Nov, 23, 11, p.1369-1376, (2017) PubMed
Central role of myeloid MCPIP1 in protecting against LPS-induced inflammation and lung injury., Y. Li; X. Huang; S. Huang; H. He; T. Lei; F. Saaoud; X.Q. Yu; A. Melnick; A. Kumar; C.J. Papasian; D. Fan; M. Fu, Signal Transduct Target Ther, 2017, 2, , p.17066, (2017) PubMed
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers., J.L. Glass; D. Hassane; B.J. Wouters; H. Kunimoto; R. Avellino; F.E. Garrett-Bakelman; O.A. Guryanova; R. Bowman; S. Redlich; A.M. Intlekofer; C. Meydan; T. Qin; M. Fall; A. Alonso; M.L. Guzman; P.J.M. Valk; C.B. Thompson; R. Levine; O. Elemento; R. Delwel; A. Melnick; M.E. Figueroa, Cancer Discov, 2017 08, 7, 8, p.868-883, (2017) PubMed
Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model., W. Du; R. Goldstein; Y. Jiang; O. Aly; L. Cerchietti; A. Melnick; O. Elemento, Cancer Res, 2017 04 15, 77, 8, p.1818-1830, (2017) PubMed
DNA Methylation-Based Biomarkers., L. Cerchietti; A. Melnick, J Clin Oncol, 2017 03, 35, 7, p.793-795, (2017) PubMed
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells., E. Valls; C. Lobry; H. Geng; L. Wang; M. Cardenas; M. Rivas; L. Cerchietti; P. Oh; S.Ning Yang; E. Oswald; C.W. Graham; Y. Jiang; K. Hatzi; X. Agirre; E. Perkey; Z. Li; W. Tam; K. Bhatt; J.P. Leonard; P.A. Zweidler-McKay; I. Maillard; O. Elemento; W. Ci; I. Aifantis; A. Melnick, Cancer Discov, 2017 05, 7, 5, p.506-521, (2017) PubMed
EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop., W. Béguelin; M.A. Rivas; M.T.Calvo Fernández; M. Teater; A. Purwada; D. Redmond; H. Shen; M.F. Challman; O. Elemento; A. Singh; A.M. Melnick, Nat Commun, 2017 10 12, 8, 1, p.877, (2017) PubMed